We succeeded in developing an anti-TMEM180 monoclonal antibody by immunizing exosomes in rats as expected [3], but because exosomes from cancer cells still contain different membrane proteins, we also established antibody clones that recognize each unknown antigen with high cancer specificity. The gene discussed is SLC68A1; the disease is cancer.